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Abstract Nephronophthisis (NPH) is an autosomal reces-
sive disease characterized by a chronic tubulointerstitial
nephritis that progress to terminal renal failure during the
second decade (juvenile form) or before the age of 5 years
(infantile form). In the juvenile form, a urine concentration
defect starts during the first decade, and a progressive
deterioration of renal function is observed in the following
years. Kidney size may be normal, but loss of cortico-
medullary differentiation is often observed, and cysts occur
usually after patients have progressed to end-stage renal
failure. Histologic lesions are characterized by tubular
basement membrane anomalies, tubular atrophy, and
interstitial fibrosis. The infantile form is characterized by
cortical microcysts and progression to end-stage renal failure
before 5 years of age. Some children present with extrarenal
symptoms: retinitis pigmentosa (Senior-Løken syndrome),
mentalretardation,cerebellar ataxia,boneanomalies,orliver
fibrosis. Positional cloning and candidate gene approaches
led to the identification of eight causative genes (NPHP1, 3,
4, 5, 6, 7, 8, and 9) responsible for the juvenile NPH and
one gene NPHP2 for the infantile form. NPH and
associated disorders are considered as ciliopathies, as all
NPHP gene products are expressed in the primary cilia,
similarly to the polycystic kidney disease (PKD) proteins.
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Introduction
Nephronophthisis (NPH), an autosomal recessive disorder
initially described in 1945 by Smith and Graham and in
1951 by Fanconi, is a chronic tubulointerstitial nephritis
that uniformly progresses to end-stage renal disease
(ESRD) [1, 2]. With regard to the age of onset for ESRD,
three clinical variants have been described: infantile,
juvenile, and adolescent forms [3]. Of these, juvenile
NPH is the most common, which accounts for 5–10% of
cases of ESRD in children. In the past, NPH and medullary
cystic kidney disease (MCKD) were considered in the same
complex. Whereas these disorders share a number of
clinical as well as histological features (tubular basement
membrane disintegration, tubular cyst formation, and
tubulointerstitial inflammation and fibrosis) [4–6], MCKD
is distinct from NPH by its autosomal dominant inheritance
and by the late onset of renal failure after the fourth decade
of life [7]. In this review, we only consider NPH.
Juvenile nephronophthisis
Juvenile NPH is an uncommon condition that affects girls
and boys equally. The incidence is approximately 0.13 for
10,000 live births in Finland, whereas in Canada, it is 1 per
50,000 live births and in United States 9 per 8.3 million [8–
10]. The disorder has been reported worldwide. The first
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Polyuria and polydipsia related to a reduced urinary
concentrating ability and loss of sodium conservation
occurs early in the course of the disease, whereas
glomerular filtration rate (GFR) remains normal [11].
Decreased urinary concentrating defect is demonstrated by
a low urinary osmolarity (<400 mosm/kg in the first urine
sample in the morning), which does not increase after
desmopressin acetate administration [5]. Urinary sodium
wasting may be responsible for hyponatremia and hypo-
volemia in cases of decreased sodium intake. Decreased
growth velocity related to chronic dehydration and later to
renal insufficiency results in growth retardation. Hematuria
and proteinuria are absent or minimal. Blood pressure is
normal before the onset of renal failure.
Renal insufficiency is often present when the diagnosis
is made. Late symptoms are related to the progressive renal
insufficiency and include anemia, metabolic acidosis,
nausea, anorexia, and weakness. ESRD develops at a mean
age of about 13 years but can also occurs in some rare cases
much later during adulthood [12, 13].
Renal ultrasound may be normal, with normal-sized
kidneys, but renal parenchymal hyperechogenicity and loss
of corticomedullary differentiation are often observed. At
later stages, small cysts are present in the medulla [14, 15].
Renal biopsy shows severe tubular damage on light
microscopy. Groups of atrophic tubules with thickened
basement membranes alternate with groups of dilated or
collapsed tubules. Homogeneous or multilayered thickening
of tubular basement membranes is prominent, but disinte-
gration of the basement membrane can also occur (Fig. 1).
Abrupt transition from one abnormality to another is highly
suggestive of juvenile NPH [16]. These various changes in
the tubular basement membrane, although nonspecific,
o c c u ri nN P Hm o r ee x t e n s i v e l yt h a ni na n yk i d n e y
disorders with abnormal tubules. There is moderate to
massive interstitial fibrosis with few inflammatory cells.
The glomeruli are often normal, although secondary
sclerosis is observed in advanced disease.
Adolescent nephronophthisis
This form of autosomal recessive NPH has been called the
adolescent form following the identification of the NPHP3
gene in a large Venezuelan family in which ESRD occurred
at a mean age of 19 years [17]. However, there is no clear
correlation between the age at ESRD and the genotype, as
some patients with an NPHP3 mutation progress to ESRD
before 10 years of age, whereas ESRD occurs in adulthood
in some patients with NPHP1 deletion. Histological lesions
are similar to those observed in juvenile NPH.
Infantile nephronophthisis
A chronic autosomal recessive tubulointerstitial nephritis
with cortical microcyts progressing to ESRD before 2 years
of age was initially described by Gagnadoux et al. [18]. The
disease differs from juvenile NPH not only by its early
onset but also by the histopathologic features. Whereas
cystic dilatations of the collecting ducts are seen in these
patients, the typical changes in the tubular basement
membranes seen in juvenile NPH are usually absent. Ultra-
sonography usually shows moderately enlarged kidneys.
Severe hypertension is common.
Associated disorders
In 10–20% of cases, extrarenal symptoms are present, in
particular, retinitis pigmentosa (RP) [Senior-Løken syn-
drome (SLS)], cerebellar ataxia [Joubert syndrome (JS)],
oculomotor apraxia type Cogan, mental retardation, bone
anomalies and hepatic fibrosis. Situs inversus and ventric-
ular cardiac septal defect are associated in some patients
with the infantile form (Table 1).
SLS, in which tapetoretinal degeneration (also known as
RP) accompanies juvenile NPH is seen in approximately
10–15% percent of cases. Initially, Senior and Løken
described patients with early and severe visual impairment
resembling Leber congenital amaurosis [19, 20], but the
syndrome has thereafter been extended to all patients with
NPH and degenerative retinopathy. In the late-onset form,
children may develop night blindness followed by complete
visual impairment in the following years. Electroretinogram
(ERG) shows complete extinction before RP may be
observed by funduscopic examination (Fig. 2). Some
Fig. 1 Renal histology of nephronophthisis. Cross-section of kidney
showing diffuse interstitial fibrosis and various tubular changes. Some
tubules are collapsed, others are surrounded by thickened tubular
basement membranes. Note the laminated and wrinkled appearance of
some tubular basement membrane segments as well as the abrupt
attenuation of others in the same tubule (Light microscopy; magnifi-
cation ×360; from Marie-Claire Gubler)
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normal. RP has been observed in association with muta-
tions in most NPHP genes (except NPHP7), but whereas
RP is always present and severe in patients with NPHP5
and NPHP6 mutations, the symptoms are in general mild in
patients with mutations in the other NPHP genes. Georges
et al. reported on four patients, from three different families,
with RP responsible for severe visual impairment during
childhood who developed chronic interstitial nephritis with
histological lesions characteristic of NPH and renal failure
only between 42 and 56 years of age [21]. No NPHP1
deletion was found in these patients, but the other genes
were not analyzed.
Nephrocystin proteins encoded by NPHP4, 5, 6, and
8 genes have been shown to localize to the connecting cilia
between the inner and outer segments of the photorecep-
tors. All components necessary for assembly, maintenance,
and turnover of the outer segment where the photo-
transduction takes place are synthesized in the cell body
and are transported through the connecting cilia. Proteins
implicated in other syndromes with retinal degeneration,
such as Bardet-Biedl [22], Alstrom [23] or Usher [24]
syndromes, have been shown to be localized to the
connecting cilia where they are probably involved in the
transport of phototransduction proteins, i.e. rhodopsin.
Perturbation of these transporters leads to degeneration of
the photoreceptor [25].
JS is an autosomal recessive neurological disorder that
associates congenital hypotonia evolving into cerebellar
ataxia, developmental delay, oculomotor apraxia, and
abnormal breathing pattern during the first month of life.
JS is characterized by a complex cerebellar and brainstem
malformation, the so-called “molar tooth sign” (MTS)
observed by magnetic resonance imaging (MRI) (Fig. 3).
JS can be associated with juvenile NPH and/or retinal
involvement (JS type B). To date, three gene loci have been
mapped to 9q34.3 (JBTS1), 11p11.2-q12.3 (JBTS2), and
6q23 (JBTS3), and mutations in the AHI1 (Abelson helper
integration site) gene have been identified in JBTS3-linked
families with a pure cerebellar phenotype [26–28].
NPHP1 homozygous deletions (identical to the deletions
o b s e r v e di np a t i e n t sw i t hi s o l a t e dN P H )h a v eb e e n
identified in a small percentage of patients with a mild
neurological form of JS and NPH (and RP in one case) [29,
30]. A recent survey of 56 families with NPHP1 deletion
revealed that 5 (8.9%) had JS-related disorders with a
variable phenotype. Most of them had no mental retarda-
tion, the characteristic MTS aspect was present in only one
Table 1 Genetic heterogeneity and overlap of nephronophthisis (NPH), Senior-Løken, Joubert, and Meckel-Gruber syndromes
Locus Chromosome Gene* Clinical manifestations
NPHP1/SLSN1 2q13 NPHP1 (nephrocystin-1) Juvenile nph (mild JBTS, mild RP, Cogan)
NPHP2 9q31 NPHP2/INVS (Inversin) Infantile nph (RP, liver fibrosis, HT)
NPHP3/SLSN3 3q22 NPHP3 (nephrocystin-3) Juvenile nph (liver fibrosis, RP)
NPHP4/SLSN4 1p36 NPHP4 (nephrocystin-4 or
nephroretinin)
Juvenile nph (Cogan, RP)
NPHP5/SLSN5 3q21 NPHP5/IQCB1 Juvenile nph + severe RP
NPHP6/SLSN6/JBTS5/
MKS4
12q21 NPHP6/CEP290 Juvenile nph + JBTS + severe RP, isolated RP,
(MKS)
NPHP7 16p NPHP7/GLIS2 Juvenile nph
NPHP8/JBTS7/MKS5 16q NPHP8/RPGRIP1L Juvenile nph + JBTS (MKS)
NPHP9 17q11 NPHP9/NEK8 Juvenile and infantile nph
JBTS Joubert syndrome type B, RP retinitis pigmentosa, MKS Meckel-Gruber syndrome, HT arterial hypertension
*The name of the protein is indicated when it is not the same as the gene
Fig. 2 Retinitis pigmentosa.
Ophtalmoscopic examinations
of a control subject (a) and an
affected individual (b) showing
typical retinitis pigmentosa fun-
dus characterized by very thin
retinal vessels, retinal pigment
epithelium atrophy, abnormal
pigmentary migrations, and pal-
lor of the optic disk
Pediatr Nephrol (2009) 24:2333–2344 2335family, and thickened superior peduncles was the only
malformation on brain MRI in two other families, whereas
it was unremarkable in one family [29]. Recently, mutations
in the NPHP6/CEP290 [31, 32]a n dNPHP8/RPGRIP1L
[33, 34] genes have been found in patients with JS. They
were associated with severe RP in the first case, whereas
there was no or only mild retinopathy in patients with
RPGRIP1L mutations. In a series of 28 patients with NPH
and at least one JS-related neurological symptom, Tory et
al. found NPHP1 and NPHP6 homozygous or compound
heterozygous mutations in 13 (46%) [35].
Meckel-Gruber syndrome (MKS) is an autosomal reces-
sive lethal disorder characterized by central nervous system
malformation (typically occipital encephalocele), postaxial
polydactyly, cystic kidney dysplasia, and ductal prolifera-
tion in the portal area of the liver [34, 36]. Interestingly,
mutations in the NPHP6, NPHP8, and MKS3 genes have
been found in patients with MKS as well as in patients with
JS, suggesting that these two conditions represent a broad
spectrum of the same underlying disorder [34, 36, 37]. As
with other genes implicated in cystic kidney diseases, most
mutated proteins responsible for MKS and JS have been
shown to be localized to kidney primary cilia, further
suggesting a connection between these syndromes.
Bone anomalies can lead to phalangeal cone-shaped
epiphyses, which are usually associated with other extra-
renal manifestations (Saldino-Mainzer syndrome) [38].
Other skeletal dysplasia are associated in different syn-
dromes. Hepatic involvement may be characterized by
hepatosplenomegaly and portal fibrosis, with no or only
mild bile duct proliferation [39–41]. Mutations of the
NPHP3 gene were reported in affected members with
hepatic fibrosis and NPH from one family [17].
Situs inversus has been reported in a patient with
infantile NPH and mutation of the NPHP2 gene [42]. This
patient also had a cardiac ventricular septal defect
(Table 2).
Several other syndromes that feature NPH have been
described, such as Jeune [43], Ellis van Creveld (chon-
droectodermal dysplasia) [44], RHYNS (retinitis pigmen-
tosa, hypopituitarism, and skeletal dysplasia) [45], Alstrom
[46], Sensenbrenner (cranioectodermal dysplasia) [47, 48],
and Arima-Dekaban [49] syndromes (Table 3). The
description of these rare syndromes is beyond the scope
of this paper.
Table 2 Extrarenal manifestations in nephronophthisis
Ocular
Isolated oculomotor apraxia (Cogan syndrome)
Retinitis pigmentosa (Senior-Løken syndrome)
Coloboma
Nystagmus (Joubert syndrome)
Ptosis (Joubert syndrome)
Neurological
Mental retardation (Joubert syndrome or isolated)
Cerebellar ataxia with vermis hypoplasia (Joubert syndrome)
Hypopituitarism (RHYNS syndrome)
Liver
Elevation of hepatic enzymes
Fibrosis, biliary duct proliferation (Boichis syndrome)
Skeletal
Phalangeal cone-shaped epiphyses (Saldino-Mainzer or
cono-renal syndrome)
Short ribs (Jeune or asphyxiating thoracic dystrophy syndrome)
Postaxial polydactyly
Skeletal dysplasia (Sensenbrenner syndrome or
cranioectodermal dysplasia)
Other:
Situs inversus
Cardiac malformations
Bronchitis
a
Sterility
a
Hyperlipemia
a
Ectodermal dysplasia (Sensenbrenner syndrome)
aPersonal data
Fig. 3 Molar tooth sign on
brain magnetic resonance imag-
ing (MRI). Brain MRI axial
image at the level of the superior
cerebellar peduncles of a control
subject (a) and an affected indi-
vidual (b) showing abnormally
increased depth of the interpe-
duncular fossa, narrowing of the
midbrain tegmentum, and thick-
ening of the superior cerebellar
peduncles, all of which contrib-
ute to the radiologic feature
known as the molar tooth sign
(white arrow)
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Positional cloning and candidate-gene approaches led to the
identification of causative genes. To date, mutations in
eight different genes (NPHP1, 3, 4, 5, 6, 7, 8, and 9) have
been identified in juvenile NPH, whereas in the infantile
form, mutations have been found in the NPHP2 gene [8]
(Fig. 4 and Table 2).
NPHP1 gene
In 1993, the first gene responsible for juvenile NPH was
localized on chromosome 2q13 by positional cloning in
consanguineous families [50]. Homozygous deletions of
about 250 kb in the 2q13 region were initially detected in
70% of patients [51, 52] and allowed identification of the
responsible gene, NPHP1, in 1997. NPHP1 contains 20
exons and encodes for a protein, named nephrocystin or
nephrocystin-1, that has an src homology 3 (SH3) and coil-
coiled domains that interact with proteins (including
products of other NPHP genes) [53, 54]. Nephrocystin
and its partners are localized at the cell–cell junction
(adherens junction) and at the cell–matrix interface (focal
adhesion), suggesting important functions in maintaining
tubular epithelium (Fig. 5)[ 55, 56]. Moreover, nephrocys-
tin-1 is also localized at the primary cilia-like proteins
associated with other cystic kidney diseases, such as
polycystins. The detection of homozygous mutations by
polymerase chain reaction (PCR) amplification permits fast
and accurate diagnosis of the disease without the need for
renal biopsy. In large series of patients with a presumptive
diagnosis of NPH based mainly on clinical and radiological
data, NPHP1 homozygous deletion is present in 20–40% of
the cases ([8] and personal data). Heterozygous deletions
are found in 6% of patients, with concomitant point
mutation of the NPHP1 gene on the second allele (personal
data). Whereas most patients with NPHP1 deletions or
mutations have no extrarenal symptoms, a moderate form
of retinal degeneration [57] or JS has been reported in some
cases [29, 30, 35, 57].
NPHP2 gene
Mutations in the NPHP2 (INVS) gene are responsible for the
infantile form of NPH. This gene, located on chromosome
9q31, encodes inversin, a protein that is critical for normal
Table 3 Syndromes featuring nephronophthisis or associated with
mutations of NPHP genes
Senior-Løken
Cogan
Joubert (type B)
Meckel-Gruber
Saldino-Mainzer (cono-renal syndrome)
Sensenbrenner (cranioectodermal dysplasia)
Ellis van Creveld (ectodermal dysplasia)
Jeune (asphyxiating thoracic dystrophy syndrome)
RHYNS (retinitis pigmentosa, hypopituitarism, and skeletal
dysplasia)
Alstrom (retinal dystrophy, hearing impairment, obesity, type 2
diabetes mellitus)
Arima-Dekaban
Boichis
Juvenile 
Nephronophthisis
Retinitis Pigmentosa
Joubert 
syndrome
NPHP5 NPHP8
NPHP6
NPHP1
AHI1 NPHP6
(and other RP genes)
NPHP1 NPHP1-3-4 NPHP2
Infantile 
Nephronophthisis
Fig. 4 Genes implicated in
nephronophthisis, retinitis, and
Joubert syndrome. Different
associations between these syn-
dromes and the corresponding
mutated genes. The most fre-
quently mutated genes are indi-
cated in large characters.
NPHP7 and NPHP9 genes are
not represented because of their
low mutation rate. Extrarenal
disorders associated with muta-
tion in the NPHP2 gene are not
indicated. Two patients with
NPHP8 mutations and mild
retinitis have been reported
[34, 74]
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proximal tubular cells, inversin is associated with neph-
rocystin-1 and with components of microtubule cytoskeleton
[59]. It is localized to different subcellular compartments,
including nuclei, cytoplasm, and cell–cell junction [60]. Its
interaction with APC2 suggests that inversin might play a
role during the cell cycle [61]. Knockout mice for the INVS
gene show large renal cysts, altered left–right laterality (situs
inversus), and hepatobiliary-duct malformations.
NPHP3 gene
NPHP3 located on chromosome 3q22 was initially mapped
in a large family of NPH patients from Venezuela [62].
Mutations in NPHP3 were described in families with renal
disease alone, as well as in families with renal disease
associated with hepatic fibrosis or retinal degeneration [17].
Age at onset of ESRD was highly variable in patients with
NPHP3 mutations from 4 to 37 years of age. Recently, two
NPH patients with ESRD at 4 years of age were found to
carry NPHP3 mutations [63]. In another recently published
byBergmannetal.,NPHP3 mutations were found in patients
with a broad clinical spectrum of early embryonic patterning
defects comprising situs inversus, polydactyly, central
nervous system malformations, structural heart defects,
preauricular fistulas and multicystic kidneys with perinatal
death in some cases [64]. NPHP3 encodes a 1,330 amino
acid protein with a tubulin-tyrosine ligase domain that
interacts with nephrocystin. Interestingly, the pcy mouse, a
spontaneously occurring renal cystic disease model that
closely resembles NPH, harbors a homozygous missense
mutation in the mouse NPHP3 ortholog (Nphp3)t h a tm o s t
likely causes the kidney phenotype [17]. Recent observations
that the pcy-associated renal cystic disease is amenable to
treatment with a vasopressin-2 receptor antagonist [65]o p e n s
new perspectives for potential therapeutic strategies in NPH,
for which no effective treatment is available.
NPHP4 gene
The NPHP4 gene located on chromosome 1p36 encodes a
1,426 amino acid protein called nephrocystin-4/nephroreti-
nin [66]. Nephrocystin-4 interacts with nephrocystin-1 and
is probably involved in the same intracellular signaling
Basal body
Primary cilium
Adherens junction
Focal adhesion
Basement membrane
Tubular lumen
Tubular
epithelium
Nephrocystin-1
inversin
Nephrocystin-4
Nephrocystin-6
Nephrocystin-
7/GLIS2
Filamin
Pyk2
P130CAS
E-cadherin
Integrin
Desmosome
Tight junction
APC2
ATF4
Nephrocystin-3,5,8,9
Nucleus
Fig. 5 Schematic representation of the tubular epithelium and
subcellular localization of the nephrocystin proteins. Nephrocystins
localize to different subcellular compartments within the cell in a cell-
cycle-dependent manner. Most nephrocystins interact with one
another, forming a nephrocystin complex. In polarized renal tubular
cells, all nephrocystin proteins localized to the primary cilia at the
base of the cilium (basal body) and in a punctate pattern along the
ciliary axoneme, suggesting their transport along the microtubule
system (red arrows). Nephrocystin-1, nephrocystin-4, and inversin
also localize to the cell–cell junctions and interact with focal adhesion
proteins (p130Cas, Pyk2). Nephrocystins also associate with proteins
associated directly with the microtubular and actin cytoskeleton
(tubulins, tensin, and filamin). These localizations suggest a role for
nephrocystins in modulating the cytoskeleton and maintaining
epithelial-cell polarity. During cell cycle, nephrocystins localize to
the centrosome. Moreover, during cell division, inversin, nephrocys-
tin-4 and nephrocystin-6 localize to the mitotic spindle. In addition,
inversin and nephrocystin-6 bind the anaphase-promoting complex
(APC2) and activating transcription factor (ATF4), respectively,
suggesting their potential involvement in cell-cycle regulation. The
transcription factornephrocystin-7/GLIS2localizedtobothnucleusand
primary cilia, as did the other NPHP proteins in renal epithelial cells
2338 Pediatr Nephrol (2009) 24:2333–2344pathway [66]. Interestingly, nephrocystin-4 is conserved in
the nematode Caenorhabditis elegans, which exhibits male
mating phenotype defect upon Nphp4 knockdown, a
phenotype also observed with orthologs of polycystic
kidney disease genes. Direct sequencing of the NPHP4
gene has been performed in 250 individuals, 190 with
isolated NPH, 50 with RP and ten with oculomotor apraxia
[67]. Twenty-three different NPHP4 mutations were found
in 26 (10%) unrelated patients (13 with isolated NPH, eight
with RP, and two with oculomotor apraxia). Of note,
nephrocystin-4 localizes to the connecting cilium of
photoreceptor cells and interacts with RPGRIP1 [RP
guanosine riphosphatase (GTPase) regulator interacting
protein 1], a component of cone and rod photoreceptors
that is mutated in patients with Leber amaurosis [68].
NPHP5 gene
In contrast to the previous NPHP genes, mutations in the
IQCB1 gene, now referred to as NPHP5, were reported only
in patients with NPH in combination with severe retinal
degeneration and early blindness—SLS [25]. NPHP5 muta-
tions, involving both alleles in all cases, were found in 16 of
92 patients with early onset RP [25]. NPHP5 encodes an IQ-
domain protein called IQCB1 or nephrocystin-5 that is
expressed in connecting cilia of photoreceptors, where it is
associated with calmodulin and retinitis pigmentosa GTPase
regulator (RPGR). Nephrocystin-5 is also present in the
primary cilia of renal epithelial cells [25].
NPHP6 gene
The NPHP6 gene, also known as CEP290, encodes a
centrosomal protein that activates ATF4, a transcription
factor involved in the control of the cell cycle. Thirteen
different mutations in the NPHP6 gene were initially
reported in 12 families with JS [31]. Most of the patients
had congenital blindness or severe visual defect in the first
years of life. In two families (patients aged 3, 9.5, 10, and
15 years), there was no renal disease. Interestingly, the
NPHP6 gene was thereafter reported to be mutated in more
than 20% of patients with severe congenital blindness but
no renal involvement (Leber congenital amaurosis) [69,
70]. A hypomorphic mutation (c.2991+1655A>G) that
creates a strong splice-donor site and inserts a cryptic exon
in the CEP290 ribonucleic acid (RNA) was detected in 16
(21%) of 76 unrelated patients with blindness but without
clinical signs of renal disease. Moreover, these patients had
no neurological symptoms typical of JS and had normal
cognitive function [69]. Another group has confirmed that
mutations in the NPHP6 gene is the most common cause of
Leber amaurosis [70]. Given the broad spectrum of the
phenotype associated with NPHP6 mutations, Helou et al.
screened this gene in 99 patients with cerebellar ataxia (JS),
75 patients with RP, and 21 patients with isolated NPH and
found mutations in seven, two, and one case, respectively
[71]. In four patients, only single heterozygous mutations
were found, and in one of them, an additional heterozygous
NPHP4 missense mutation was present, arguing for a
digenic inheritance. A genome-wide linkage scan in
families with MKS led to the identification of NPHP6
mutations in some patients [36].
NPHP7 gene
The NPHP7 gene, also known as the GLIS2 gene, contains
six coding exons and encodes a Kruppel-like zinc-finger
transcription factor, which has been found mutated in one
consanguineous Oji-Cree Canadian family with isolated
NPH in three children who developed ESRD by 8 years of
age. This gene seems to be very rarely involved, as no other
mutation was found in a cohort of 470 individuals with NPH-
like phenotypes [72]. The kidneys of mice with a targeted
disruption of the Glis2 gene are atrophic, with fibrosis
starting at 8 weeks of age. Apoptosis is increased in renal
tubular cells, whereas cell proliferation is not. Interestingly,
the genes promoting epithelial–mesenchymal transition and
fibrosis are up-regulated in the absence of Glis2.
NPHP8 gene
Mutations in a novel gene on chromosome 16, RPGRIP1L,
have been found in patients with JS and in fetuses with
MKS [34]. Interestingly, Delous et al. reported that MKS
fetuses carried two truncating mutations, whereas JS
patients carried missense mutations and/or one truncating
mutation, suggesting a genotype–phenotype correlation
[34]. RPGRIP1L is a cytosolic protein that colocalizes at
the basal bodies, centrosomes, and primary cilia in renal
tubular cells with nephrocystin-4 and nephrocystin-6 [34].
Interestingly, missense mutations found in JS patients
decrease the interaction of RPGRIP1L with nephrocystin-
4 without affecting its localization, suggesting that a defect
in this association may contribute to the phenotype [33, 34].
In the same lines, NPHP4 missense mutations known to
cause NPH with RP also disrupt this interaction [33].
Recently, it was shown that Rpgrip1l participates in sonic
hedgehog (Shh) signaling and by this means plays a critical
role in patterning of the developing neural tube and limb
through the cilium [73]. The RPGRIP1L gene was
thereafter analyzed in a cohort of 56 patients with JS.
RPGRIP1L mutations were identified in five kindreds,
including six individuals (8%). Of note, patients with
RPGRIP1L mutations had normal retina, except two
patients out of 12 with moderate visual impairment [34,
74]. Additional clinical symptoms were present in some
Pediatr Nephrol (2009) 24:2333–2344 2339patients with RPGRIP1L mutations, such as liver fibrosis,
postaxial polydactyly, pituitary agenesis, and partial growth
hormone deficiency. These last findings indicate a possible
overlap with RHYNS syndrome [34, 74].
NPHP9
The jck cystic kidney mouse model is associated with a
mutation in the Nek8 gene [75]. Analysis of the NEK8 gene
in a cohort of 588 patients with NPH led to the
identification of three missense mutations in patients with
isolated NPH [76]. In one patient, an additional mutation in
the NPHP5 gene was also present. Interestingly, mutant
forms of NEK8 showed defects in ciliary localization.
Genetic heterogeneity and oligogenism
Overall, NPHP1 to NPHP9 mutations have been reported
in cases of juvenile NPH with or without extrarenal
symptoms, except for mutations in NPHP2 that have been
found only in patients with infantile NPH. NPHP1
mutations were found in ~20% to 40% of cases [8],
whereas mutations in the other genes seem to account for
a very low percentage of cases (Table 1). Analysis of the
NPHP1, NPHP3, and NPHP4 genes in a cohort of 94
different families have shown that a mutation or a deletion
in one of these three genes was identified in 44 (47%)
patients [77]. Interestingly, in six families, three muta-
tions in two NPHP genes were found, whereas two
mutations in two NPHP genes (NPHP3 and NPHP4)w e r e
found in another kindred. Finally, a single mutation in one
of these three genes was discovered in nine other patients
[77]. In the same lines, Tory et al. found that some patients
with NPH and at least one JS-related neurological
symptom had both an NPHP1 deletion and either a
heterozygous NPHP6 or AHI1 mutation [35]. These
findings demonstrate that similar to the inheritance
patterns described in Bardet-Biedl syndrome (BBS),
NPH, at least in some patients, follows a digenic or
oligogenic inheritance with heterozygous mutations in
different genes in the same patients. Sequencing of all the
known NPH genes in a large cohort of patients will be
necessary to validate this model and appreciate the
mutation load that could account for the severity of the
nephropathy as well as the extrarenal symptoms.
The cilia connection
Cilia are present in almost all cells in the organism and act as
sensory organelles that connect visual, mechanosensory,
odorant or other stimuli to cell-cycle, control of epithelial
architecture, or other yet unknown processes. The finding
that polycystin-1 and polycystin-2—the proteins responsible
for autosomal dominant polycystic kidney disease [78]a n d
proteins involved in other cystic kidney diseases (BBS [22],
oro-facio-digital syndrome [79])—were present in cilia in
Clinical suspicion of
nephronophthisis
NPHP1 positive
Juvenile nephronophthisis
negative
Renal biopsy
Other
diagnosis
Isolated
renal disease
Severe RP Cerebellar  ataxia, 
without severe RP
NPHP5 NPHP 8
Severe RP and
cerebellar ataxia
NPHP 6
Age at ESRD
< 5 years > 5 years
NPHP2
Fig. 6 Decision algorithm for
genetic analyses when nephro-
nophthisis is suspected on clin-
ical and radiological basis. At
first, NPHP1 or NPHP2 genes
should be screened for muta-
tions, depending on the age at
onset of end-stage renal disease.
The other genes are analyzed in
function of extrarenal symp-
toms. NPHP3, NPHP4, NPHP7,
and NPHP9 genes are currently
not sequenced for diagnostic
purposes because of their low
mutation rate. RP retinitis pig-
mentosa
2340 Pediatr Nephrol (2009) 24:2333–2344renal tubular cells indicates a possible connection between
this organelle and cyst formation. It has been suggested that
the primary cilium senses fluid movement in the renal
tubules. The presence of cystoproteins (such as nephrocys-
tins) in cilia of various organs (photoreceptor, ependymal
cells, cholangiocytes, chondrocytes) explains the multiple
organ involvement in some patients with NPH. To illustrate
this unifying theory, the term ciliopathies has been coined to
design all the syndromes related to dysfunction of ciliary
proteins. For more information on this subject, the readers
are referred to an excellent recent review [80].
Conclusions
In conclusion, and from a practical point of view, the
diagnosis of NPH should be considered if a child presents
with polyuria, urinary sodium loss, growth failure, renal
insufficiency without hematuria or proteinuria, normal
blood pressure, and normal-sized kidneys without dilatation
of the urinary tract. These patients should be screened for
homozygous or heterozygous NPHP1 deletion, which is
found in 20–40% of cases. In the absence of such deletion,
renal biopsy may be proposed to confirm the diagnosis. At
present, screening for mutation in all the other NPHP genes
is not routinely performed due to the low frequency of
detected mutations and the high cost of the procedure.
Patients with associated disorders should be considered
separately. In case of severe RP, the NPHP5 gene may be
screened for mutations, whereas in patients with neurolog-
ical symptoms such as cerebellar ataxia, the NPHP6 and
NPHP8 genes should be analyzed first. In case of early
onset tubulointerstitial nephritis with cortical microcysts,
the NPHP2 gene should be screened for mutation (Fig. 6).
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Questions
(Answers appear after the reference list)
1. The diagnosis of nephronophthisis may be suspected
in a child with chronic renal failure and
A) a past history of polyuria
B) de Toni-Debré-Fanconi syndrome
C) a chronic tubulointerstitial nephritis on renal
biopsy
D) two large kidneys on renal ultrasound
E) consanguineous parents
2. The following extra-renal symptoms may be observed
in a child with nephronophthisis
A) hepatomegaly
B) tapetoretinal degeneration
C) cone-shaped epiphysis
D) cerebellar ataxia
E) diabetes mellitus
3. Children with mutations in the NPHP2 gene
A) develop end stage renal disease after 10 years of
age
B) have cortical microcysts on renal biopsy
C) may present with situs inversus
D) often develop severe hypertension
E) may present with Senior-Løken syndrome
4. Kidneys in juvenile nephronophthisis are characterized
by
A) tubulo-interstitial fibrosis
B) mesangial hypercellularity
C) tubular basement membrane irregularities
D) cortical cysts
E) tubular atrophy
5. Juvenile nephronophthisis is genetically characterized
by
A) a recessive mode of inheritance
B) mutations in NPHP5 and NPHP6 genes in patients
with severe retinal dystrophy
C) mutation in more than one gene in some patients
D) a more severe disease in males
E) NPHP1 gene deletion in 20 to 30% of the patients
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